Skip to main content

Find Clinical Trials

Home
Conditions
DNA Virus Infections

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,911 public trials 503 recruiting studies

Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

High Dose IMVAMUNE® in Vaccinia-Naive Individuals

NCT00879762

Conditions: DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations: University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States

Saint Louis University Center for Vaccine Development St Louis, Missouri, United States

View Trial Details

Completed

A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years

NCT05989672

Conditions: DNA Virus Infections, Herpes Simplex, Herpesviridae Infections, +6 more
Locations: GSK Investigational Site Tokyo, Japan

View Trial Details

Completed

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

NCT03448393

Conditions: Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Lymphoid Leukemia, +33 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Efficacy of Probiotic Lactobacillus Crispatus M247 in Promoting High-risk Human Papillomavirus (HR-HPV) Infection Clearance and Modifying Vaginal Microbiota

NCT06802809

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: Azienda Ospedaliero Universitaria Policlinico "G. Rodolico-San Marco" Catania, Italy

Nuovo Ospedale di Lentini Lentini, Italy

Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo Palermo, Italy

View Trial Details

Completed

Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes

NCT05446532

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: H. Consorci Sanitari Parc Tauli Sabadell, Barcelona, Spain

View Trial Details

Completed

Assessing the Reliability of Self-Reported Hepatitis B Vaccination Status in Outpatients: Evaluation of Individuals Born in France and Consulting at the CeGIDD in Saint-Denis.

NCT06998992

Conditions: Ambulatory Care, Behavior, Blood-Borne Infections, +14 more
Locations: France Saint-Denis, France

View Trial Details

Completed

Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066)

NCT04772534

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +10 more
Locations: Sotobo Children's Clinic ( Site 6616) Isumi, Chiba, Japan

Ohigesenseino Kodomo Clinic ( Site 6607) Sapporo, Hokkaido, Japan

Motomachi Pediatric Clinic ( Site 6606) Sapporo, Hokkaido, Japan

Medical Corporation Bunmeikai Okuda E.N.T ( Site 6611) Sakai, Osaka, Japan

View Trial Details

Completed

Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)

NCT03783078

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +15 more
Locations: Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) New York, United States

Icahn School of Medicine at Mount Sinai ( Site 0004) New York, United States

Melanoma Institute Australia ( Site 0400) North Sydney, New South Wales, Australia

Calvary Mater Newcastle ( Site 0402) Waratah, New South Wales, Australia

View all 22 locations

View Trial Details

Completed

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

NCT02988466

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Bone Marrow Failure Disorders, +53 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection

NCT05123599

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: UZ Antwerpen Edegem, Belgium

UZA-SGS Edegem, Belgium

Hopital Beaujon Clichy, France

Hopital de La Croix Rousse Lyon, France

View all 13 locations

View Trial Details